ALK-positive plasmablastic B-cell lymphoma with the clathrin-ALK gene rearrangement

Pediatr Blood Cancer. 2006 Mar;46(3):390-1. doi: 10.1002/pbc.20540.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Anaplastic Lymphoma Kinase
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Asparaginase / administration & dosage
  • Child
  • Chromosomes, Human, Pair 17 / genetics
  • Chromosomes, Human, Pair 2 / genetics
  • Clathrin / genetics*
  • Daunorubicin / administration & dosage
  • Female
  • Gene Expression Regulation, Leukemic
  • Gene Rearrangement / genetics*
  • Humans
  • Lymphoma, B-Cell / drug therapy
  • Lymphoma, B-Cell / genetics*
  • Lymphoma, B-Cell / pathology
  • Oncogene Proteins, Fusion / genetics*
  • Prednisone / administration & dosage
  • Protein-Tyrosine Kinases / genetics*
  • Receptor Protein-Tyrosine Kinases
  • Translocation, Genetic / genetics
  • Vincristine / administration & dosage

Substances

  • Clathrin
  • Oncogene Proteins, Fusion
  • Vincristine
  • ALK protein, human
  • Anaplastic Lymphoma Kinase
  • Protein-Tyrosine Kinases
  • Receptor Protein-Tyrosine Kinases
  • Asparaginase
  • Prednisone
  • Daunorubicin

Supplementary concepts

  • PVDA protocol